TTK Healthcare
1,167.10
+36.30(+3.21%)
Market Cap₹1,597.90 Cr
PE Ratio25.44
IndustryDiversified
Company Performance:
1D+3.21%
1M-1.05%
6M-6.26%
1Y-29.74%
5Y+166.25%
View Company Insightsright
More news about TTK Healthcare
23May 25
TTK Healthcare Reports Mixed Q4 Results, Declares ₹10 Dividend
TTK Healthcare's Q4 results show revenue growth to ₹1.90 billion, up 5.56% year-over-year. However, profitability declined with EBITDA falling to ₹120.00 million and net profit decreasing to ₹161.00 million. Despite challenges, the company declared a dividend of ₹10.00 per share.
02May 25
TTK Healthcare Faces Setback as USAID Cancels Condom Procurement Agreement
TTK Healthcare announced the cancellation of its agreement with Chemonics due to USAID's decision to stop condom procurement from the company. This has left TTK Healthcare with unsold inventory worth ₹58.60 million. The company plans to explore remedies, including potential legal action, to mitigate the impact of this contract cancellation.
TTK Healthcare
1,167.10
+36.30
(+3.21%)
1 Year Returns:-29.74%
Industry Peers
Godrej Industries
1,081.90
(-0.06%)
3M India
29,565.00
(+0.58%)
DCM Shriram Consolidated
1,234.40
(+1.30%)
Swan Corp
427.10
(-0.71%)
Sindhu Trade Links
25.36
(+0.83%)
Balmer Lawrie & Co
200.52
(-0.71%)
TTK Healthcare
1,167.10
(+3.21%)
Dhunseri Ventures
296.10
(-19.49%)
Empire Industries
1,065.00
(-0.93%)